Oxford Nanopore Receives Regulatory Approval for its First Diagnostic Device in the UK and Europe
Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic (“IVD”) device in the UK and Europe: the GridION
Dx.
OXFORD, England–(BUSINESS WIRE)–#Nanopore–Oxford Nanopore Technologies today announces that the GridION Dx is now both CE and UKCA marked, making it the company’s first IVD device registered in the UK and Europe. The CE and UKCA certification confirms that GridION Dx meets stringent international standards for quality, safety, and performance, positioning Oxford Nanopore for future adoption in regulated clinical markets and reflecting its long-term commitment to sequencing-based diagnostics.
“Being CE and UKCA marked for GridION Dx is an important step as we build the foundations for clinical use in regulated markets,” said Gordon Sanghera, CEO Oxford Nanopore Technologies. “This milestone demonstrates regulatory readiness and supports the deployment of GridION Dx as a diagnostic product for use in clinical environments within the UK and Europe.”
GridION Dx will initially be available through specified partnerships, with the first application being infectious disease characterisation. The Oxford Nanopore platform delivers information-rich insights and rapid time to results, in a way that is accessible and affordable – critical factors for shaping future clinical workflows and enabling expansion into areas such as oncology and genetic conditions.
The first product, available in partnership with bioMérieux, will integrate with AmPORE-TB, a multidrug-resistant tuberculosis assay, and underscores this strategic approach. bioMérieux is a world leader in the field of in vitro diagnostics recognised for its extensive portfolio of CE-marked solutions spanning microbiology, immunoassays, and molecular biology. AmPORE-TB has been introduced as a research use only (“RUO”) application and, already in clinical trials, is on a defined pathway towards a fully regulated IVD assay on GridION Dx. This underlines both companies’ commitment to bringing sequencing-based tuberculosis testing to clinical settings over time.
Dr Charles K. Cooper, Executive Vice President, Chief Medical Officer, bioMérieux stated: “The regulatory approval of GridION Dx represents a major milestone in expanding access to innovative sequencing-based solutions like AmPORE-TB. This achievement brings us closer to equipping healthcare professionals with advanced tools to combat antimicrobial resistance, enabling faster, more informed decisions and improving patient outcomes worldwide.”
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used in more than 125 countries to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments.
Oxford Nanopore Technologies products are intended for molecular biology applications and are not intended for diagnostic purposes. For more, visit: https://nanoporetech.com/
Contacts
Contact Oxford Nanopore Technologies
Media@nanoporetech.com
You May Also Like
Flora Growth Announces $401M Funding to Boost AI Zero Gravity (0G) Coin Treasury
Highlights: Flora Growth announces $401M PIPE financing round aimed at establishing an AI Zero Gravity (0G) coin treasury. DeFi Development Corp. led the fundraising exercise with strong support from other companies. Flora Growth will rebrand to ZeroStack following the successful completion of the PIPE financing round. One of the world’s leading decentralised artificial intelligence (AI) treasury companies, Flora Growth, has announced the pricing of a $401 million private investment in public equity (PIPE) round. According to a September 19 press release, the move aims to fund the firm’s treasury strategy centred on AI Zero Gravity (0G) tokens. Upon completion of the PIPE round, Flora Growth will rebrand to ZeroStack, while still maintaining its current market ticker symbol, FLGC. Notably, the financing round is expected to close on or before September 26, 2025, pending customary approvals. Flora Growth Corp. (NASDAQ: FLGC) announced a $401 million PIPE financing led by Defi Development Corp., Hexstone Capital, and CSAPL. 0G Co-Founder Michael Heinrich will become Executive Chairman. The deal is expected to close on September 26. The company will adopt $0G as its… — Wu Blockchain (@WuBlockchain) September 19, 2025 Flora Growth Announces $401M PIPE with Strong Backing from Leading Crypto Firms DeFi Development Corp. (DFDV), the first treasury firm focused on Solana (SOL), led the financing round with a $22.88 million investment. Other partners included Hexstone Capital, Dispersion Capital, Blockchain Builders Fund, Carlsberg SE Asia PTE Ltd (CSAPL), Abstract Ventures, Salt, and Dao5. The fundraising exercise has already generated $35 million in cash commitments and $366 million worth of in-kind digital assets. Flora Growth sold its common shares and pre-funded warrants to investors at $25.19 per share. The company also pegged 0G tokens contribution at $3 per coin, adding that investors paying either cash or 0G tokens will also receive pre-funded warrants, exercisable once shareholder approval is granted. A big NASDAQ company (Flora Growth) just announced they’re raising $401 million. ︎ They plan to buy and hold $0G tokens as part of their company’s savings/treasury. Flora’s deal values $0G at around $3 per token for their planned purchase. Right now $0G is trading below… pic.twitter.com/qhOa3uT5ii — Jimmywontgiveup(Ø,G) (@jimmywontgiveup) September 20, 2025 Flora Growth Plans to Hold SOL in Its Treasury Flora Growth noted that it plans to hold part of its treasury in SOL. Joseph Onorati, the CEO of DeFi Development Corp., spoke on the partnership.“We’re thrilled to partner with FLGC on this fundraiser and look forward to driving a deep collaboration between 0G and Solana,” the CEO stated. Daniel Reis-Faria, Flora Growth’s incoming Chief Executive Officer (CEO), also spoke on the company’s latest initiative. He explained that the move encompasses financial restructuring and support for adopting AI infrastructures. The CEO commented: “This treasury strategy offers institutional investors equity-based exposure, enabling transparent, verifiable, large-scale, cost-efficient, and privacy-first AI development.” A Brief 0G Token Overview, Highlighting Reasons for Flora Growth’s Interest 0G is gaining significant traction, which has made experts describe the token as a breakthrough in decentralised AI. 0G’s model trained a 107 billion AI parameter model, representing a 357x improvement over Google’s DiLoCo research, challenging the idea that huge centralised data centres are needed for such projects. The 0G network proved that a decentralised network is highly effective for cost-effective computations, with transparent and privacy-first solutions. Unlike other AI blockchains, 0G integrated its computation, storage, and training marketplace into one platform, attracting Web2 and Web3 developers. In related news, Crypto2Community reported that Brera Holdings, an Ireland-based company, completed a $300 million PIPE financing round for a Solana-focused treasury on September 19. The fundraising program was led by Pulsar Group, a blockchain advisory firm based in the UAE. It received strong backing from the Solana Foundation, RockawayX, and ARK Invest. Like Flora Growth, Brera Holdings also rebranded to Solmate. eToro Platform Best Crypto Exchange Over 90 top cryptos to trade Regulated by top-tier entities User-friendly trading app 30+ million users 9.9 Visit eToro eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk. Don’t invest unless you’re prepared to lose all the money you invest. This is a high-risk investment, and you should not expect to be protected if something goes wrong.
XRP Whales Accumulate as Retail Pulls Back — Bullish Signal Ahead
